Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor
- PMID: 1713211
Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor
Abstract
The involvement of the low density lipoprotein receptor-related protein (LRP) in chylomicron remnant (CR) catabolism was investigated. Ligand blot analyses demonstrated that beta-very low density lipoproteins (beta-VLDL) incubated with apolipoprotein E (beta-VLDL+E) bound to the LRP and low density lipoprotein receptors, whereas active (receptor-binding) alpha 2-macroglobulin (alpha 2M) bound only to LRP partially purified from rat liver membranes. Iodinated beta-VLDL+E and active alpha 2M showed high affinity binding to the LRP/alpha 2M receptor of low density lipoprotein receptor-negative fibroblasts. The binding and degradation of radiolabeled alpha 2M by these cells were partially inhibited by beta-VLDL+E. Furthermore, alpha 2M interfered with the internalization of beta-VLDL+E and subsequent induction in the cholesterol esterification by these cells. These studies suggested that remnant lipoproteins and active alpha 2M compete for binding to the LRP/alpha 2M receptor. Next, we examined whether the LRP/alpha 2M receptor plays a role, in the presence of low density lipoprotein receptors, in the in vivo catabolism of CR in mice. In vivo studies demonstrated that the unlabeled active, but not the native, alpha 2M partially inhibited the plasma clearance and hepatic uptake of radiolabeled CR or apoE-enriched radiolabled CR. Likewise, apoE-enriched CR retarded the plasma clearance and hepatic uptake of radiolabeled active alpha 2M. These studies provide physiological evidence that the LRP/alpha 2M receptor may function as a CR receptor that removes CR from the plasma.
Similar articles
-
Blockade of the alpha 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein on rat liver parenchymal cells by the 39-kDa receptor-associated protein leaves the interaction of beta-migrating very-low-density lipoprotein with the lipoprotein remnant receptor unaffected.Eur J Biochem. 1996 Dec 15;242(3):703-11. doi: 10.1111/j.1432-1033.1996.0703r.x. Eur J Biochem. 1996. PMID: 9022700
-
In vivo removal of beta-VLDL, chylomicron remnants, and alpha 2-macroglobulin in the rat.J Lipid Res. 1993 Feb;34(2):309-15. J Lipid Res. 1993. PMID: 7679138
-
Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.J Biol Chem. 1993 May 15;268(14):10160-7. J Biol Chem. 1993. PMID: 7683668
-
The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins.Biol Chem Hoppe Seyler. 1994 Aug;375(8):485-95. doi: 10.1515/bchm3.1994.375.8.485. Biol Chem Hoppe Seyler. 1994. PMID: 7811390 Review.
-
Receptor-mediated mechanisms of lipoprotein remnant catabolism.Prog Lipid Res. 1998 Dec;37(6):393-422. doi: 10.1016/s0163-7827(98)00017-4. Prog Lipid Res. 1998. PMID: 10209655 Review.
Cited by
-
Lipometabolism and Glycometabolism in Liver Diseases.Biomed Res Int. 2018 Dec 12;2018:1287127. doi: 10.1155/2018/1287127. eCollection 2018. Biomed Res Int. 2018. PMID: 31205932 Free PMC article. Review.
-
Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the 39-kd receptor-associated protein in human trophoblasts.Am J Pathol. 1994 Feb;144(2):383-92. Am J Pathol. 1994. PMID: 7508685 Free PMC article.
-
Expression of different lipoprotein receptors in natural killer cells and their effect on natural killer proliferative and cytotoxic activity.Immunology. 1995 Nov;86(3):399-407. Immunology. 1995. PMID: 8550077 Free PMC article.
-
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.J Clin Invest. 1998 Apr 15;101(8):1726-36. doi: 10.1172/JCI2181. J Clin Invest. 1998. PMID: 9541504 Free PMC article.
-
Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.J Clin Invest. 1998 May 15;101(10):2151-64. doi: 10.1172/JCI1599. J Clin Invest. 1998. PMID: 9593771 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous